TABILAUTIDE - AN OVERVIEW

Patients that are acquiring cyclosporine, tacrolimus or other agents to circumvent graft-versus-host disorder submit bone marrow transplant usually are not eligible for this demoExperimental: Dose expansion_sub-population 2_higher dose of niraparib MTDs and/or candidate RP2Ds for elimusertib utilized in combination with niraparib at an increased fa